Literature DB >> 1934415

Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery.

L R Smith1, F E Harrell, J S Rankin, R M Califf, D B Pryor, L H Muhlbaier, K L Lee, D B Mark, R H Jones, H N Oldham.   

Abstract

Most analyses of risk factors affecting survival after coronary artery bypass graft surgery have not differentiated among factors that influence early and late survival. For this reason, a multiphase model was applied to survival data from 2,967 patients undergoing a first coronary artery bypass graft at the Duke University Medical Center between 1969 and 1984. There were 709 deaths during follow-up to 19.6 years. The data were analyzed using a multivariable survival model that separates the underlying hazard function into as much as three different phases, each incorporating separate risk factors. Two distinct phases were detected. One phase dominated early survival (0-1 year), and the second phase dominated late survival (greater than 1 year). Surgery performed earlier in our experience was associated with elevated risk of dying in both phases but with different magnitudes, whereas lower ejection fraction, greater extent of coronary disease, older age, conduction abnormality, and history of hypertension were associated with elevated risk of dying similarly in both phases (p less than 0.05). Severity of angina symptoms and lower weight were associated with an elevated risk of dying only in the early phase (p less than 0.05; because few of the patients were obese, estimates of the relative risk of morbid obesity could not be estimated), whereas vascular disease, diabetes, and extent of myocardial damage were associated with an elevated risk of dying only in the late phase (p less than 0.05). These data illustrate both the differential influence of risk factors over time and the importance of multiphase models.

Entities:  

Mesh:

Year:  1991        PMID: 1934415

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Nuclear cardiology will remain the "gatekeeper" over CT angiography.

Authors:  Rory Hachamovitch; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

2.  ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention.

Authors:  Svati H Shah; Elizabeth R Hauser; David Crosslin; Liyong Wang; Carol Haynes; Jessica Connelly; Sarah Nelson; Jessica Johnson; Shera Gadson; Charlotte L Nelson; David Seo; Simon Gregory; William E Kraus; Christopher B Granger; Pascal Goldschmidt-Clermont; L Kristin Newby
Journal:  Atherosclerosis       Date:  2008-02-12       Impact factor: 5.162

3.  Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization.

Authors:  Sayanti Bhattacharya; Christopher B Granger; Damian Craig; Carol Haynes; James Bain; Robert D Stevens; Elizabeth R Hauser; Christopher B Newgard; William E Kraus; L Kristin Newby; Svati H Shah
Journal:  Atherosclerosis       Date:  2013-11-12       Impact factor: 5.162

4.  Long-term benefits of internal thoracic artery-coronary artery bypass in Japanese patients.

Authors:  S Kitamura; K Kawachi; S Taniguchi; T Kawata; S Kobayashi; H Nishioka; K Mizuguchi; K Niwaya; Y Kameda; H Sakaguchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-01

Review 5.  Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications.

Authors:  Hiroshi Ito
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

6.  SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization.

Authors:  Josephine H Li; Sunil Suchindran; Svati H Shah; William E Kraus; Geoffrey S Ginsburg; Deepak Voora
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

7.  Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease.

Authors:  Benjamin D Horne; John F Carlquist; Joseph B Muhlestein; Tami L Bair; Jeffrey L Anderson
Journal:  Circ Cardiovasc Genet       Date:  2008-12

8.  Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7α-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression.

Authors:  Danxin Wang; Katherine Hartmann; Michal Seweryn; Wolfgang Sadee
Journal:  Circ Genom Precis Med       Date:  2018-10

9.  Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.

Authors:  Beth S Sutton; David R Crosslin; Svati H Shah; Sarah C Nelson; Anthony Bassil; A Brent Hale; Carol Haynes; Pascal J Goldschmidt-Clermont; Jeffery M Vance; David Seo; William E Kraus; Simon G Gregory; Elizabeth R Hauser
Journal:  Hum Mol Genet       Date:  2008-01-18       Impact factor: 6.150

10.  Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.

Authors:  Svati H Shah; Neil J Freedman; Lisheng Zhang; David R Crosslin; David H Stone; Carol Haynes; Jessica Johnson; Sarah Nelson; Liyong Wang; Jessica J Connelly; Michael Muehlbauer; Geoffrey S Ginsburg; David C Crossman; Christopher J H Jones; Jeffery Vance; Michael H Sketch; Christopher B Granger; Christopher B Newgard; Simon G Gregory; Pascal J Goldschmidt-Clermont; William E Kraus; Elizabeth R Hauser
Journal:  PLoS Genet       Date:  2009-01-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.